Fourteen‐Day Tegoprazan–Amoxicillin Dual Therapy as the First‐Line Treatment of Helicobacter pylori Infection (SHARE2301): A Multicenter, Noninferiority, Randomized Clinical Trial

Documenti analoghi

• Efficacy of Tetracycline Three Times Daily was Comparable to That of Four Times Daily for Helicobacter pylori Rescue Treatment: A Multicenter, Noninferiority, Randomized Controlled Trial
  di: Zhongxue Han, et al.
  Pubblicazione: (2024)
• Tegoprazan‐Amoxicillin Dual Therapy for Helicobacter pylori Eradication: A Prospective, Randomized, Multicenter Study in Fujian, China
  di: Xueyan Lin, et al.
  Pubblicazione: (2024)
• Antibiotic Combinations in Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Network Meta‐Analysis
  di: Miao Duan, et al.
  Pubblicazione: (2025)
• Seven‐Day Versus 14‐Day Tegoprazan and Tetracycline‐Containing Quadruple Therapy for First‐Line Eradication of Helicobacter pylori Infection: A Randomized, Open‐Label, Noninferiority Trial
  di: Xue‐Ping Nan, et al.
  Pubblicazione: (2025)
• Clarifying varied Helicobacter pylori eradication therapies: A comprehensive review
  di: Xiaoqi Wu, et al.
  Pubblicazione: (2024)